After graduating from Osaka University School of Pharmaceutical Studies, she received the Kusumoto Award (Osaka University) and her license to practice pharmacy. In 1996, she finished her masters at the Osaka University Graduate School and School of Pharmaceutical Studies. She received her Ph.D. in Pharmaceutical Studies in 2004, as well as received the Inoue Research Award for Young Scientists.
In 1996, she partook in chemical compound screening development at Aurora Biosciences Inc., a venture company from the University of California, San Diego. She participated in molecular biology research at the University of California, Los Angeles in 1997, Ontario Institute for Cancer Research and University of Toronto in 1999, and RIKEN Center for Integrative Medical Sciences (formerly RIKEN Research Center for Allergy and Immunology) in 2003.
Shinobu participated in exploratory research for drug development at Bayer Yakuhin, Ltd. (formerly Nihon Schering K.K.) in 2005 and Nippon Boehringer Ingelheim Co., Ltd. in 2007. In 2014, after serving as the Medical Science Liaison at AbbVie Inc. in 2013, she went on to pursue open innovation in drug development Nippon Boehringer Ingelheim Co., Ltd.